Eli Lilly & Co. will sponsor MDLinx's journal aggregator smartphone application for a year. The drugmaker will not promote any products via the app, which allows users to share abstracts and specify content type, and offers access to editorial summaries and third-party reviews. Lilly sales reps will promote the app to clinicians.

Related Summaries